Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens DOI Creative Commons
Zachary D. Wallen, Mary Appah, Marissa Dean

и другие.

npj Parkinson s Disease, Год журнала: 2020, Номер 6(1)

Опубликована: Июнь 12, 2020

Abstract In Parkinson’s disease (PD), gastrointestinal features are common and often precede the motor signs. Braak colleagues proposed that PD may start in gut, triggered by a pathogen, spread to brain. Numerous studies have examined gut microbiome PD; all found it be altered, but inconsistent results on associated microorganisms. Studies date been small ( N = 20 306) difficult compare or combine due varied methodology. We conducted microbiome-wide association study (MWAS) with two large datasets for internal replication 333 507). used uniform methodology when possible, interrogated confounders, applied statistical tests concordance, followed correlation network analysis infer interactions. Fifteen genera were at significance level, both datasets, methods, without covariate adjustment. The associations not independent, rather they represented three clusters of co-occurring Cluster 1 was composed opportunistic pathogens elevated PD. 2 short-chain fatty acid (SCFA)-producing bacteria reduced 3 carbohydrate-metabolizing probiotics Depletion anti-inflammatory SCFA-producing levels confirmatory. Overabundance is an original finding their identity provides lead experimentally test role

Язык: Английский

Parkinson's disease DOI
Bastiaan R. Bloem, Michael S. Okun, Christine Klein

и другие.

The Lancet, Год журнала: 2021, Номер 397(10291), С. 2284 - 2303

Опубликована: Апрель 11, 2021

Язык: Английский

Процитировано

2279

The gut microbiota–brain axis in behaviour and brain disorders DOI
Lívia H. Morais, Henry L. Schreiber, Sarkis K. Mazmanian

и другие.

Nature Reviews Microbiology, Год журнала: 2020, Номер 19(4), С. 241 - 255

Опубликована: Окт. 22, 2020

Язык: Английский

Процитировано

1494

Gut microbial metabolites as multi-kingdom intermediates DOI
Kimberly A. Krautkramer, Jing Fan, Fredrik Bäckhed

и другие.

Nature Reviews Microbiology, Год журнала: 2020, Номер 19(2), С. 77 - 94

Опубликована: Сен. 23, 2020

Язык: Английский

Процитировано

930

Interaction between drugs and the gut microbiome DOI Creative Commons
Rinse K. Weersma, Alexandra Zhernakova, Jingyuan Fu

и другие.

Gut, Год журнала: 2020, Номер 69(8), С. 1510 - 1519

Опубликована: Май 14, 2020

The human gut microbiome is a complex ecosystem that can mediate the interaction of host with their environment. between microbes and commonly used non-antibiotic drugs bidirectional: composition be influenced by drugs, but, vice versa, also influence an individual's response to drug enzymatically transforming drug's structure altering its bioavailability, bioactivity or toxicity (pharmacomicrobiomics). indirectly impact immunotherapy in cancer treatment. In this review we discuss bidirectional interactions describe changes microbiota induced potential clinical consequences summarise how impacts effectiveness role immunotherapy. Understanding metabolises reduces treatment efficacy will unlock possibility modulating improve

Язык: Английский

Процитировано

712

Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders DOI Open Access
Yijing Chen, Jinying Xu, Yu Chen

и другие.

Nutrients, Год журнала: 2021, Номер 13(6), С. 2099 - 2099

Опубликована: Июнь 19, 2021

Emerging evidence indicates that gut microbiota is important in the regulation of brain activity and cognitive functions. Microbes mediate communication among metabolic, peripheral immune, central nervous systems via microbiota–gut–brain axis. However, it not well understood how microbiome neurons mutually interact or these interactions affect normal functioning cognition. We summarize mechanisms whereby regulate production, transportation, neurotransmitters. also discuss dysbiosis affects function, especially neurodegenerative diseases such as Alzheimer’s disease Parkinson’s disease.

Язык: Английский

Процитировано

556

Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation DOI Creative Commons
Stefano Romano, George M. Savva, Janis R. Bedarf

и другие.

npj Parkinson s Disease, Год журнала: 2021, Номер 7(1)

Опубликована: Март 10, 2021

The gut microbiota is emerging as an important modulator of neurodegenerative diseases, and accumulating evidence has linked microbes to Parkinson's disease (PD) symptomatology pathophysiology. PD often preceded by gastrointestinal symptoms alterations the enteric nervous system accompany disease. Several studies have analyzed microbiome in PD, but a consensus on features PD-specific missing. Here, we conduct meta-analysis re-analyzing ten currently available 16S datasets investigate whether common patients exist across cohorts. We found significant PD-associated microbiome, which are robust study-specific technical heterogeneities, although differences structure between controls small. Enrichment genera Lactobacillus, Akkermansia, Bifidobacterium depletion bacteria belonging Lachnospiraceae family Faecalibacterium genus, both short-chain fatty acids producers, emerged most consistent alterations. This dysbiosis might result pro-inflammatory status could be recurrent affecting patients.

Язык: Английский

Процитировано

506

Personalized Mapping of Drug Metabolism by the Human Gut Microbiome DOI Creative Commons
Bahar Javdan, Jaime G Lopez, Pranatchareeya Chankhamjon

и другие.

Cell, Год журнала: 2020, Номер 181(7), С. 1661 - 1679.e22

Опубликована: Июнь 1, 2020

Язык: Английский

Процитировано

347

Fecal Microbiota Transplantation in Neurological Disorders DOI Creative Commons
Karuna E.W. Vendrik, Rogier E. Ooijevaar,

Pieter R. C. de Jong

и другие.

Frontiers in Cellular and Infection Microbiology, Год журнала: 2020, Номер 10

Опубликована: Март 24, 2020

Background Several studies suggested an important role of the gut microbiota in pathophysiology neurological disorders, implying that alteration might serve as a treatment strategy. Fecal transplantation (FMT) is currently most effective intervention and accepted for recurrent Clostridioioides difficile infections. To evaluate indications FMT patients with we summarized available literature on FMT. In addition, provide suggestions future directions. Methods July 2019, five main databases were searched case descriptions disorders humans or animal models. ClinicalTrials.gov website was consulted registered planned ongoing trials. Results Of 541 identified studies, 34 included analysis. Clinical trials have been performed autism spectrum disorder showed beneficial effects symptoms. For multiple sclerosis Parkinson's disease, several positive effect FMT, supported by some reports humans. epilepsy, Tourette syndrome, diabetic neuropathy but evidence restricted to limited numbers studies. stroke, Alzheimer's disease Guillain-Barré syndrome only models identified. These potential healthy donor contrast, one study model stroke increased mortality after Whether findings from can be confirmed human diseases awaits seen. above mentioned are ongoing, well amyotrophic lateral sclerosis. Conclusions Preliminary suggests may promising option disorders. However, still scanty contrasting results observed. Limited while experiments conducted. Large double-blinded randomized controlled needed further elucidate

Язык: Английский

Процитировано

336

Mass spectrometry-based metabolomics in microbiome investigations DOI
Anelize Bauermeister, Helena Mannochio-Russo, Letícia V. Costa‐Lotufo

и другие.

Nature Reviews Microbiology, Год журнала: 2021, Номер 20(3), С. 143 - 160

Опубликована: Сен. 22, 2021

Язык: Английский

Процитировано

334

A metabolomics pipeline for the mechanistic interrogation of the gut microbiome DOI
Shuo Han,

Will Van Treuren,

Curt R. Fischer

и другие.

Nature, Год журнала: 2021, Номер 595(7867), С. 415 - 420

Опубликована: Июль 14, 2021

Язык: Английский

Процитировано

308